| pubmed-article:8109121 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8109121 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
| pubmed-article:8109121 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
| pubmed-article:8109121 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:8109121 | lifeskim:mentions | umls-concept:C0030274 | lld:lifeskim |
| pubmed-article:8109121 | lifeskim:mentions | umls-concept:C0442045 | lld:lifeskim |
| pubmed-article:8109121 | lifeskim:mentions | umls-concept:C0002978 | lld:lifeskim |
| pubmed-article:8109121 | lifeskim:mentions | umls-concept:C1273870 | lld:lifeskim |
| pubmed-article:8109121 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:8109121 | pubmed:dateCreated | 1994-3-22 | lld:pubmed |
| pubmed-article:8109121 | pubmed:abstractText | A prospective study was undertaken to evaluate selective visceral angiography (SVA) in the management of patients with pancreatic and periampullary cancer. Over a 30-month period 52 patients with potentially resectable pancreatic or periampullary cancer underwent SVA; 4 patients had obvious angiographic evidence of widely disseminated disease and were not subjected to laparotomy while 2 further patients were eventually considered too frail for resection. The remaining 46 patients (median age 58 years, range 37-73 years, males 26, females 20) had no evidence of disseminated disease on ultrasonography and/or CT scanning and had both SVA and surgery and form the basis of this study. Vascular anomalies were detected in 16/46 (35%) patients. Hepatic metastases were wrongly diagnosed by angiography in 7 out of 9 patients (77%). SVA correctly predicted resectability or irresectability in 28/46 patients (overall predictive value 61%). Of the 27 patients who proved to have irresectable disease at operation, 11 were correctly identified by SVA (sensitivity 41%). Of the 13 patients reported to have irresectable disease, 2 underwent resection (false-positive rate 15%). Of the 33 patients reported to have resectable disease, 16 were irresectable (false-negative rate 48%). Overall there was a poor relationship between resectability and the angiographic features. On the basis of these data, SVA cannot be considered a sufficiently accurate means of assessing resectability. Its use for this purpose in patients with pancreatic and periampullary cancer is not justified. | lld:pubmed |
| pubmed-article:8109121 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8109121 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8109121 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8109121 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8109121 | pubmed:issn | 0364-2313 | lld:pubmed |
| pubmed-article:8109121 | pubmed:author | pubmed-author:CarterD CDC | lld:pubmed |
| pubmed-article:8109121 | pubmed:author | pubmed-author:SurSS | lld:pubmed |
| pubmed-article:8109121 | pubmed:author | pubmed-author:GardenO JOJ | lld:pubmed |
| pubmed-article:8109121 | pubmed:author | pubmed-author:RedheadD NDN | lld:pubmed |
| pubmed-article:8109121 | pubmed:author | pubmed-author:WindsorJ AJA | lld:pubmed |
| pubmed-article:8109121 | pubmed:author | pubmed-author:MurugiahMM | lld:pubmed |
| pubmed-article:8109121 | pubmed:author | pubmed-author:O'NeillJ SJS | lld:pubmed |
| pubmed-article:8109121 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8109121 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:8109121 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8109121 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8109121 | pubmed:pagination | 796-800 | lld:pubmed |
| pubmed-article:8109121 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:8109121 | pubmed:meshHeading | pubmed-meshheading:8109121-... | lld:pubmed |
| pubmed-article:8109121 | pubmed:meshHeading | pubmed-meshheading:8109121-... | lld:pubmed |
| pubmed-article:8109121 | pubmed:meshHeading | pubmed-meshheading:8109121-... | lld:pubmed |
| pubmed-article:8109121 | pubmed:meshHeading | pubmed-meshheading:8109121-... | lld:pubmed |
| pubmed-article:8109121 | pubmed:meshHeading | pubmed-meshheading:8109121-... | lld:pubmed |
| pubmed-article:8109121 | pubmed:meshHeading | pubmed-meshheading:8109121-... | lld:pubmed |
| pubmed-article:8109121 | pubmed:meshHeading | pubmed-meshheading:8109121-... | lld:pubmed |
| pubmed-article:8109121 | pubmed:meshHeading | pubmed-meshheading:8109121-... | lld:pubmed |
| pubmed-article:8109121 | pubmed:meshHeading | pubmed-meshheading:8109121-... | lld:pubmed |
| pubmed-article:8109121 | pubmed:meshHeading | pubmed-meshheading:8109121-... | lld:pubmed |
| pubmed-article:8109121 | pubmed:meshHeading | pubmed-meshheading:8109121-... | lld:pubmed |
| pubmed-article:8109121 | pubmed:articleTitle | The role of selective visceral angiography in the management of pancreatic and periampullary cancer. | lld:pubmed |
| pubmed-article:8109121 | pubmed:affiliation | University Department of Surgery, Royal Infirmary of Edinburgh, Scotland. | lld:pubmed |
| pubmed-article:8109121 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8109121 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8109121 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8109121 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8109121 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8109121 | lld:pubmed |
